These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7032812)

  • 1. Role of dopamine in the regulation of blood pressure and the renin--angiotensin--aldosterone system in conscious rats.
    Kondo K; Ebihara A; Suzuki H; Saruta T
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():235s-237s. PubMed ID: 7032812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central and peripheral effects of dopamine on the renin-angiotensin-aldosterone system in conscious rats.
    Kondo K; Suzuki H; Handa M; Nagahama S; Yasui T; Fujimaki M; Ogihara T; Saruta T
    Jpn Circ J; 1981 Sep; 45(9):1121-5. PubMed ID: 7029031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of the central effects of dopamine and metoclopramide on aldosterone regulation in the rat.
    Kawabe H; Kondo K; Hayashi M; Fujimaki M; Nagahama S; Saruta T
    Endocrinol Jpn; 1983 Aug; 30(4):543-9. PubMed ID: 6323152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1979 Apr; 63(4):727-35. PubMed ID: 438333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic control of aldosterone secretion is independent of the renin-angiotensin system in rats.
    Sowers JR; Tuck ML; Barrett J; Sambhi MP; Golub MS
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():101s-103s. PubMed ID: 7004716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central dopaminergic regulation of aldosterone secretion in sheep.
    Huang BS; Malvin RL; Lee J; Grekin RJ
    Hypertension; 1987 Aug; 10(2):157-63. PubMed ID: 3301664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pressor and hormonal responses to intravenous injection of metoclopramide in normotensive and hypertensive patients.
    Kawabe H; Suzuki H; Itaya Y; Saruta T
    Jpn J Med; 1990; 29(2):174-9. PubMed ID: 2232366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intracerebroventricular administration of dopamine and metoclopramide on blood pressure in rats.
    Kondo K; Suzuki H; Handa M; Nagahama S; Saruta T
    Arch Int Pharmacodyn Ther; 1981 Apr; 250(2):273-8. PubMed ID: 7271387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Escape from the sodium-retaining effects of mineralocorticoids: is there a role for dopamine?
    Coruzzi P
    J Clin Endocrinol Metab; 1994 Feb; 78(2):455-8. PubMed ID: 8106635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of central and peripheral dopamine antagonism on aldosterone secretion: evidence for adrenal mechanism.
    Stern N; Eggena P; Chandler W; Tuck ML
    Am J Physiol; 1989 Oct; 257(4 Pt 1):E588-94. PubMed ID: 2679132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic modulation of aldosterone secretion: effect of sodium balance and postural changes.
    García-Robles R; Ruilope L; Mancheño E; Hurtado A; Alcázar JM; Varela C; de la Calle H; Rodicio JL; Sancho J
    Rev Esp Fisiol; 1984 Mar; 40(1):63-8. PubMed ID: 6087430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of metoclopramide and haloperidol on plasma renin activity and aldosterone levels in rats.
    Jungmann E; Wächtler M; Schwedes U; Usadel KH; Schöffling K
    Res Exp Med (Berl); 1983; 183(2):133-8. PubMed ID: 6361937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo and in vitro effects of metoclopramide on aldosterone secretion in rats.
    Nagahama S; Fujimaki M; Suzuki H; Kawabe H; Saito I; Saruta T
    Acta Endocrinol (Copenh); 1983 Apr; 102(4):589-93. PubMed ID: 6342328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic control of aldosterone secretion in hypertensive patients chronically treated with an angiotensin converting enzyme inhibitor.
    Waeber B; Nussberger J; Schaller MD; Gomez HJ; Brunner HR
    Horm Metab Res; 1986 Jan; 18(1):60-3. PubMed ID: 3005150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of aldosterone secretion by metoclopramide is not affected by chronic converting enzyme inhibition.
    Dupont AG; Vanderniepen P; Smitz JJ; Six RO
    Eur J Clin Pharmacol; 1985; 29(2):207-10. PubMed ID: 3000795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic blockade of the renin-angiotensin-aldosterone system: effect of high and low sodium intakes.
    Gordon MB; Moore TJ; Dluhy RG; Williams GH
    Clin Endocrinol (Oxf); 1983 Oct; 19(4):415-25. PubMed ID: 6354522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal by a dopamine antagonist of saline-induced attenuation of aldosterone response to angiotensin II infusion in man.
    Kojima I; Ogata E
    Endocrinol Jpn; 1982 Feb; 29(1):21-5. PubMed ID: 7049683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of metoclopramide administration on electrolyte status and activity of renin-angiotensin-aldosterone system in premature infants.
    Sulyok E; Ertl T; Varga L; Bódis J; Csaba IF
    Pediatr Res; 1985 Sep; 19(9):912-5. PubMed ID: 3900902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of dopaminergic antagonists on plasma aldosterone in normal subjects and patients with hypopituitarism].
    Shikuma R; Yoshimura M; Takashina R; Yamazaki H; Kambara S; Ijichi H
    Nihon Naibunpi Gakkai Zasshi; 1984 Sep; 60(9):1041-5. PubMed ID: 6394371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic receptor mechanisms modulating the renin-angiotensin system and aldosterone secretion: an overview.
    Missale C; Lombardi C; De Cotiis R; Memo M; Carruba MO; Spano PF
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S29-39. PubMed ID: 2483440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.